However, it is hard for one to deny the fact that scientific research activities are culminated [8], waiting for new issues. Hence, it is right time that we search for how to reactivate scientific research activities both inside and outside the community. It is said that the relatively ...
Oral MRX-I demonstrated efficacy equal to or better than LNZ in mouse models with local and systemic infection [125]. GSK-656 GSK-656, a new compound, belongs to the drug class of oxaborole. It acts as a leukyl-tRNA synthetase inhibitor and is currently in phase I clinical trials. ...
cancers Review Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? Jens von der Grün 1 , Franz Rödel 1,2,3,4, Christian Brandts 3,4,5, Emmanouil Fokas 1,2,3,4, Matthias Guckenberger 6, Claus ...